IRWD IRONWOOD PHARMACEUTICALS INC
2026Q1 · CUSIP 46333X108 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
222
Δ holders QoQ
+22
Breadth percentile
Top 14%
Whale holders
117
Δ whales
+8
Inst. holding value
$561M
New positions
52
Closed positions
30
Price momentum (1Q)
-26.8%
Put / Call
4/5
Breadth history (34 quarters)
Past Lit Events & Aftermath 7 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 14% | — | — |
| 2025Q4 | Top 16% | -26.8% | — |
| 2022Q3 | Top 15% | +5.2% | -7.0% |
| 2022Q2 | Top 6% | -4.6% | -6.7% |
| 2021Q3 | Top 9% | -10.6% | -7.2% |
| 2019Q4 | Top 13% | -4.5% | -15.0% |
| 2019Q3 | Top 13% | +4.9% | +3.9% |
Options Sentiment
Put holders
4
QoQ: +2
Call holders
5
QoQ: +1
See methodology →
Fundamentals
PE (TTM)
6.4
EPS (TTM)
$0.60
EPS YoY
—
Revenue (TTM)
$0.4B
Revenue YoY
+13.8%
Net margin
28.3%
ROE
—
Debt ratio
150.0%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.